Expression of Rat Liver Tryptophan 2,3-Dioxygenase inEscherichia coli:Structural and Functional Characterization of the Purified Enzyme

• Published in: Archives of biochemistry and biophysics Vol. 333; no. 1; pp. 96 - 102
• Main Authors: Ren, Shiyan, Liu, Hanguan, Licad, Estefania, Correia, Maria Almira
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.09.1996
• ISSN: 0003-9861; 1096-0384
• DOI: 10.1006/abbi.1996.0368

The hepatic hemoprotein tryptophan 2,3-dioxygenase (TDO) is the key regulatory enzyme that, through irreversible degradation, controls the flux of tryptophan through physiologically relevant pathways. This enzyme is composed of four identical subunits and in its fully assembled tetrameric form requires 2 mol of heme (Fe+2-protoporphyrin IX)/mol of protein for functional competence. Using a full-length cDNA for the rat liver TDO subunit (pUC119/TDO) as the template, TDO cDNA was amplified by polymerase chain reaction (PCR) and incorporated into the expression vector pTrc99A after introduction of convenient restriction sites as well as modification of the second codon AGT to GCT to optimize its bacterial expression. DH5αF′ strainEscherichia colicells transfected with this pTrc99A/TDO construct expressed soluble, functionally active, tetrameric TDO protein in high yields. The enzyme was isolated from 30,000gsupernatant of cell lysates, purified by ion-exchange chromatography, and its spectral and catalytic properties were assessed in terms of its substrate and prosthetic moiety specificities. In almost all aspects, the bacterially expressed enzyme was found to be identical to that of the rat liver. Heterologous expression of the fully functional enzyme, we trust, will enable future elucidation of its structure–function relationships.